Based on integrative analyses of transcriptomic landscape and urinary signature, the urine-based prognostic classifier consisting of VSIG4, TGFBI, and P4HB has satisfied predictive power of survival time, pathological grade and stage in ccRCC patients, which facilitate ccRCC molecular subtyping and treatment. This evidence concerns the gene VSIG4 and nonpapillary renal cell carcinoma.